TY - JOUR
T1 - Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.
AU - Hambardzumyan, Karen
AU - Bolce, Rebecca
AU - Saevarsdottir, Saedis
AU - Cruickshank, Scott E
AU - Sasso, Eric H
AU - Chernoff, David
AU - Forslind, Kristina
AU - Petersson, Ingemar
AU - Geborek, Pierre
AU - van Vollenhoven, Ronald F
PY - 2015
Y1 - 2015
N2 - Prediction of radiographic progression (RP) in early rheumatoid arthritis (eRA) would be very useful for optimal choice among available therapies. We evaluated a multi-biomarker disease activity (MBDA) score, based on 12 serum biomarkers as a baseline predictor for 1-year RP in eRA.
AB - Prediction of radiographic progression (RP) in early rheumatoid arthritis (eRA) would be very useful for optimal choice among available therapies. We evaluated a multi-biomarker disease activity (MBDA) score, based on 12 serum biomarkers as a baseline predictor for 1-year RP in eRA.
U2 - 10.1136/annrheumdis-2013-204986
DO - 10.1136/annrheumdis-2013-204986
M3 - Article
C2 - 24812287
VL - 74
SP - 1102
EP - 1109
JO - Annals of the Rheumatic Diseases
JF - Annals of the Rheumatic Diseases
SN - 1468-2060
IS - 6
ER -